Self-Identification Program
Recruiting · NCT06183359 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Montpellier
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Conduct a pilot, single-center, randomized controlled 2-arm study aimed to evaluate the impact of an in-depth 3rd wave CBT program targeting correct self-identification (3rd level of 3rd wave CBT), compared to a control group receiving an acceptance and commitment therapy (ACT; (1st level of 3rd wave CBT, a well-known psychotherapy). Main judgment criteria : Therapeutic response (reduction ≥ 50% between pre and immediate post-treatment), and rate of relapse at 6 months post-therapy. Secondary objectives: Evaluate psychological processes involved in the reduction of moral pain, diligence, ruminations, suicidal ideas, self-concept and alterations in functioning (mental and social), psychological skills.
Who can take part
Inclusion criteria
- Patients aged 18 to 70 years, presenting a current major depressive episode (according to DSM 571), as part of unipolar or bipolar depressive disorder
Exclusion criteria
- Patients with a psychotic disorder
- Patients with active thoughts of suicide with intention to carry out the act (C-SSRS "ideation suicidal" in the last week ≥ 4)
- Inability to receive informed information about the study
- Exclusion period determined by a previous study
- Adult protected by law or patient under guardianship or curatorship
- Not be affiliated to a French social security scheme or beneficiary of such a scheme
- Not being able to give informed written consent
- Pregnant or breastfeeding women
- Patients under judicial protection
Where it is running
1 location listed.
- CHU Montpellier - Montpellier, France